Catalent (CTLT)
(Delayed Data from NYSE)
$58.40 USD
-0.02 (-0.03%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $58.42 +0.02 (0.03%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 41% (100 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.60 | 1.52 | 9.99 |
Current Quarter Estimate | 0.46 | -2.04 | 61.00 |
Year Ago Quarter Estimate | 0.09 | -0.59 | 54.84 |
Next Quarter Estimate | 0.03 | -2.00 | 63.00 |
Next Year Estimate | 1.17 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -87.00 | 13.30 | NA |
Next Year | 800.00 | 16.00 | NA |
Last 5 Years | -11.10 | 7.00 | 8.10 |
Next 5 Years | 29.20 | 25.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 2.93 | 1.82 |
Price/Cash Flow (MRFY) | 18.01 | 8.53 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -26.61% | -315.56% |
Return on Equity (TTM) | -2.73% | -82.03% |
Debt to Equity (MRQ) | NA | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.